Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S2 from NAD+ Metabolic Enzyme Inhibitor as Radiosensitizer for Malignant Meningioma and its Modulation of P53 Expression
  1. Home
  2. Publications
  3. Supplementary Table S2 from NAD+ Metabolic Enzyme Inhibitor as Radiosensitizer for Malignant Meningioma and its Modulation of P53 Expression

Supplementary Table S2 from NAD+ Metabolic Enzyme Inhibitor as Radiosensitizer for Malignant Meningioma and its Modulation of P53 Expression

Authors:
  • YLYifan Lv
    Yifan Lv
  • YDYuxuan Deng
    Yuxuan Deng
  • JFJie Feng
    Jie Feng
  • JLJinqiu Liu
    Jinqiu Liu
  • MYMingxu Yang
    Mingxu Yang
  • ZPZhuonan Pu
    Zhuonan Pu
  • SZShaodong Zhang
    Shaodong Zhang
  • Zhen Wu
    Zhen Wu
  • NJNan Ji
    Nan Ji
  • DPDeric M. Park
    Deric M. Park
  • SHShuyu Hao
    Shuyu Hao

Open Access
Publisher website
Google Scholar
  • 6 November 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.27623739
Abstract
No abstract available
Keywords
  • CNS CANCERS
  • DRUG TARGETS
  • RADIATION ONCOLOGY
  • RADIOPROTECTORS AND RADIOSENSITIZERS
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.